EudraLex
From Wikipedia, the free encyclopedia
European Union |
This article is part of the series: |
|
|
Other countries • Politics Portal |
EudraLex is the collection of rules and regulations governing medicinal products in the European Union.
EudraLex consists of 10 volumes:
- Concerning Medicinal Products for Human use:
- Volume 1 - Pharmaceutical Legislation.
- Volume 2 - Notice to Applicants.
- Volume 2A deals with procedures for marketing authorisation.
- Volume 2B deals with the presentation and content of the application dossier.
- Volume 2C deals with Guidelines.
- Volume 3 - Guidelines.
- Concerning Medicinal Products for human use in clinical trials (investigational medicinal products).
- Volume 10 - Clinical trials
- Concerning Veterinary Medicinal Products:
- Volume 5 - Pharmaceutical Legislation.
- Volume 6 - Notice to Applicants.
- Volume 7 - Guidelines.
- Volume 8 - Maximum residue limits.
- Concerning Medicinal Products for Human and Veterinary use:
- Volume 4 - Good Manufacturing Practices
- Volume 9 - Pharmacovigilance
- Miscellaneous:
- Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)
[edit] Directives
- Directive 65/65/EEC1
- Directive 75/318/EEC
- Directive 75/319/EEC
- Directive 93/41/EEC
- Directive 2001/20/EC
- Directive 2001/83/EC
- Directive 2005/28/EC
[edit] See also
- European Union law
- European Union directive
- European Commission
- Directorate-General
- EUR-Lex
- Regulatory requirement
- Regulation of therapeutic goods
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
- Good Clinical Practice
- European Medicines Agency
- EUDRANET
- EudraVigilance
- Title 21 of the Code of Federal Regulations (USA)
- Drug development
[edit] External links
- News on Pharmaceuticals, (European Union)
- EudraLex
- EUR-Lex
- Review of pharmaceutical legislation (EU DG Enterprise and Industry)
- Directorate General Enterprise and Industry (European Comission)